Attached files
file | filename |
---|---|
EX-32.1 - EXHIBIT 32.1 - Aptose Biosciences Inc. | ex_268362.htm |
EX-31.2 - EXHIBIT 31.2 - Aptose Biosciences Inc. | ex_268361.htm |
EX-31.1 - EXHIBIT 31.1 - Aptose Biosciences Inc. | ex_268360.htm |
10-Q - FORM 10-Q - Aptose Biosciences Inc. | apto20210630_10q.htm |
Exhibit 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Jotin Marango, the Senior Vice President and Chief Financial Officer of Aptose Biosciences Inc. (the “Company”), hereby certify that, to my knowledge:
1. The Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 3, 2021
/s/ Jotin Marango Name: Jotin Marango, M.D., Ph.D. Title: Senior Vice President and Chief Financial Officer |